Trial Profile
A study investigating the immunosuppressive activity of Acthar gel in sarcoidosis patients by analysing cytokine levels
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Sarcoidosis
- Focus Pharmacodynamics
- 23 Feb 2017 New trial record